Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labo International is a Swiss-headquartered dermo-cosmetic and healthcare company specialized in the research and development of non-invasive aesthetic treatments. Established in 1986, the company is globally recognized for its patented 'Crescina' hair regrowth solutions and 'Fillerina' dermo-cosmetic fillers, which serve as topical alternatives to traditional injectable treatments. Labo's core innovation is its Transdermic Technology, a delivery platform that utilizes specific molecular weights to facilitate the deep penetration of active ingredients into the skin and scalp. The company maintains a strong intellectual property portfolio with numerous international patents and conducts clinical trials to validate the efficacy of its formulations. Operating from dual headquarters in Switzerland and Italy, Labo distributes its products through pharmacies and high-end clinics across more than 40 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labo International.